COVID-19 vaccine prevents 8,600 deaths in 7 months = South Korea

An analysis has found that vaccination against the COVID-19 virus prevented 8,600 deaths over seven months. The Korea Disease Control Agency has determined that the COVID-19 virus virus has been identified as a result of an analysis of epidemiological data in Korea.
It was revealed on the 31st that vaccination with V. japonica prevented more than 8,600 deaths between January and July 2023 (weeks 1 to 30), based on August 31, when 100% surveillance was implemented.
In addition, as a result of evaluating the effectiveness of the bivalent vaccine inoculated by more than 10,000 people aged 65 and over from December last year to May this year, it was found that the risk of hospitalization for vaccinated people was one-eighth (12
.4%) level, the risk of death fell to one-fifth (21.7%) level. The World Health Organization (WHO) also has a new XBB. 1.5 monovalent vaccine currently contains HK.3, the dominant strain in South Korea
The Agency for Disease Control said it recommended vaccination as it was confirmed to be effective against the XBB substrain. As of 6 p.m. on the 29th of this month, the cumulative number of people aged 65 and over who have been vaccinated is 3,935,140, and the cumulative vaccination rate is 40.
It was calculated as .3%. This is a higher vaccination rate than the vaccination rate for the same period last year (31.2%). Notably, 4 out of 10 people over 65 participated in the COVID-19 vaccination.
The government recommends that COVID-19 vaccinations be implemented until COVID-19 is transformed into a regular infectious disease that can be managed by the general medical system, like influenza.
The plan is to continue working to protect high-risk groups. Ji Young-mi, director of the Agency for Disease Control and Prevention, said, ``Amidst the recent outbreak of various respiratory infections such as influenza, hospitalizations and deaths due to the COVID-19 virus have increased.
"As deaths continue to occur, it is important for high-risk groups to be vaccinated in a timely manner to reduce the risk of hospitalization and death," he said, emphasizing the need for vaccination.